Inicio / Gastroenterología / Abstracts de gastroenterología / Epstein–Barr virus status is a promising biomarker for endoscopic resection in early gastric cancer: proposal of a novel therapeutic strategy

Epstein–Barr virus status is a promising biomarker for endoscopic resection in early gastric cancer: proposal of a novel therapeutic strategy

0 / 5 (0 votos)
Epstein–Barr virus status is a promising biomarker for endoscopic resection in early gastric cancer: proposal of a novel therapeutic strategy

Journal of Gastroenterology

Fecha de publicación: 2 March 2019

DOI: https://doi.org/10.1007/s00535-019-01562-0

Autores: Hiroki Osumi, Hiroshi Kawachi, Toshiyuki Yoshio, Satoshi Ida, Noriko Yamamoto, Yusuke Horiuchi, Akiyoshi Ishiyama, Toshiaki Hirasawa, Tomohiro Tsuchida, Naoki Hiki, Kengo Takeuchi, Junko Fujisaki.

Background: Epstein–Barr virus-positive gastric cancer (EBVGC) is associated with a low prevalence of lymph node metastasis (LNM); however, EBV status is not considered in the indication of endoscopic resection (ER). We aimed to clarify the implication of EBV status for ER of pT1b GC.

Comentarios

Para dejar un comentario antes debes iniciar sesión:

¿No tienes una cuenta?

Regístrate a través de éste enlace.